Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential

Joshua D Welch1,2, Jeanette Baran-Gale3,4, Charles M Perou5,6,7

  • 1Curriculum in Bioinformatics and Computational Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. jwelch@cs.unc.edu.

BMC Genomics
|March 14, 2015
PubMed
Abstract

Insights

Pseudogenes are transcribed and can act as competing endogenous RNAs (ceRNAs) in cancer. This study developed a new method to identify transcribed pseudogenes in breast cancer, revealing their widespread regulatory roles.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Pseudogenes are increasingly recognized for their roles in cancer when dysregulated.
  • Pseudogene transcripts can function as competing endogenous RNAs (ceRNAs), but their study is limited by sequence similarity and lack of integrated miRNA data.
  • Previous research on pseudogenes in breast cancer has not performed large-scale analysis of ceRNA potential by integrating miRNA expression data.

Purpose of the Study:

  • To investigate the pervasive regulatory role of transcribed pseudogenes in cancer.
  • To develop a novel bioinformatic method for measuring pseudogene transcription from RNA-seq data.
  • To analyze the ceRNA potential of pseudogenes in breast cancer using integrated expression data.

Main Methods:

  • Developed a novel bioinformatic method to quantify pseudogene transcription from RNA-seq data.
  • Applied the method to 819 breast cancer samples from The Cancer Genome Atlas (TCGA).
  • Integrated pseudogene, gene, and miRNA expression data with miRNA target prediction for ceRNA analysis.

Main Results:

  • Identified 440 transcribed pseudogenes in breast cancer tissue, with 309 showing differential expression across subtypes.
  • Pseudogene expression levels accurately separated tumor from normal samples and distinguished Basal from Luminal and Her2 subtypes.
  • Found more significant pseudogene-parent gene correlations and pseudogene-miRNA anti-correlations than expected by chance, with 177 pseudogenes predicted to act as ceRNAs.

Conclusions:

  • Pseudogene transcription is widespread in breast cancer and plays a significant regulatory role.
  • The developed method enables large-scale analysis of pseudogene transcription and ceRNA potential.
  • Results expand the catalog of putative pseudogene ceRNAs and highlight their underappreciated role in breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K